KÜÇÜKKARAPINAR, M. Et Al. 2022. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress. JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8 , 1077-1089.

KÜÇÜKKARAPINAR, M., Yay-Pence, A., YILDIZ, Y., BÜYÜKKÖRÜK, M., YAZ AYDIN, G., Deveci-Bulut, T. S., ... GÜLBAHAR, Ö.(2022). Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress. JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8, 1077-1089.

KÜÇÜKKARAPINAR, MELİKE Et Al. "Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress," JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8, 1077-1089, 2022

KÜÇÜKKARAPINAR, MELİKE Et Al. "Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress." JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8, pp.1077-1089, 2022

KÜÇÜKKARAPINAR, M. Et Al. (2022) . "Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress." JOURNAL OF NEURAL TRANSMISSION , vol.129, no.8, pp.1077-1089.

@article{article, author={MELİKE KÜÇÜKKARAPINAR Et Al. }, title={Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress}, journal={JOURNAL OF NEURAL TRANSMISSION}, year=2022, pages={1077-1089} }